MALLORI MCBRYDE: Open Payments
NPI 1801671425 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,674 in 85 payments from 36 companies in 2025. Trend: 2023 $89 · 2024 $2,292 · 2025 $1,674
Food & beverage: $1,674
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $129 |
| Legend Biotech USA Inc. | 6 | $126 |
| Celgene Corporation | 4 | $105 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| Daiichi Sankyo Inc. | 4 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| Merck Sharp & Dohme LLC | 4 | $82 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| PFIZER INC. | 4 | $71 |
| Lilly USA, LLC | 3 | $58 |
Products named: CARVYKTI, REBLOZYL, Nubeqa, KEYTRUDA, OJJAARA, ENHERTU, VERZENIO, JEMPERLI.
Industry payments across MS — which companies pay providers there.
